evidence based medicine

Insurance Journal | “Direct to Consumer Genetic Testing: Risks and Opportunities”

Click Here to Learn More About How Concierge Medicine Physicians Are Adopting Advanced Healthcare Testing Tools …

By Katharina Ó Cathaoir | April 14, 2017   

Accurate genetic testing stands to transform modern medicine by offering effective, personalized treatment. Last week, the U.S. Food and Drug Administration (FDA) authorized marketing of the first direct-to-consumer (DTC) genetic health risk (GHR) tests. Individuals in the U.S. can now purchase DTC tests and gain potentially useful information on their genetic predisposition to 10 diseases or conditions, such as late-onset Alzheimer’s or Parkinson’s disease.


Support For Use of Whole Genome Sequencing in Concierge Medicine

CONCLUSION  Genetic testing is certainly here to stay. Greater genetic awareness and information could encourage patient mobilization and demands for personalized medicine. 23andme is the world’s largest bio/databank and individuals are given the option to donate samples. So beyond individual information, research breakthroughs may be on the horizon should individuals choose to donate their samples for further study.


SOURCE: http://www.insurancejournal.com/news/national/2017/04/14/447812.htm

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s